Showing results (21-30 of 497) with videos related to
Sort By:
Pageof 50
Journal of Basic and Clinical Physiology and Pharmacology|September 24, 2016
Neuropharmacological and neurochemical evaluation of N-n-propyl-3-ethoxyquinoxaline-2-carboxamide (6n): a novel serotonergic 5-HT3 receptor antagonist for co-morbid antidepressant- and anxiolytic-like potential using traumatic brain injury model in ratsShvetank Bhatt, Radhakrishnan Mahesh, Ankur Jindal, et al.Pharmacological Reports : PR|August 24, 2014
Neuropharmacological effect of novel 5-HT3 receptor antagonist, N-n-propyl-3-ethoxyquinoxaline-2-carboxamide (6n) on chronic unpredictable mild stress-induced molecular and cellular response: Behavioural and biochemical evidencesShvetank Bhatt, Radhakrishnan Mahesh, Ankur Jindal, et al.Neurochemistry International|December 19, 2016
Molecular modifications by regulating cAMP signaling and oxidant-antioxidant defence mechanisms, produce antidepressant-like effect: A possible mechanism of etazolate aftermaths of impact accelerated traumatic brain injury in rat modelAnkur Jindal, Radhakrishnan Mahesh, Shvetank Bhatt, et al.Contributions to Nephrology|May 9, 2013
Obesity and heart failure as a mediator of the cerebrorenal interactionAnkur Jindal, Adam Whaley-Connell, James R SowersJournal of Basic and Clinical Physiology and Pharmacology|September 25, 2016
Neuropharmacological evaluation of a novel 5-HT3 receptor antagonist (4-benzylpiperazin-1-yl)(3-methoxyquinoxalin-2-yl) methanone (6g) on lipopolysaccharide-induced anxiety models in miceShvetank Bhatt, Radhakrishnan Mahesh, Thangaraj Devadoss, et al.Gastro Hep Advances|October 6, 2025
Use of Noninvasive Tests to Assess Clinically Significant Portal Hypertension and Response to Beta-BlockersOmkar S Rudra, Ankur Jindal, Shiv Kumar SarinWorld Journal of Oncology|October 7, 2017
Malignant Retroperitoneal Extra-Gastrointestinal Stromal Tumor: A Unique EntityShalini Thapar Laroia, Taruna Yadav, Archana Rastogi, et al.The American Journal of Gastroenterology|May 27, 2020
Clinical Decompensation and Outcomes in Patients With Compensated Cirrhosis and a Hepatic Venous Pressure Gradient ≥20 mm HgAnkur Jindal, Ankit Bhardwaj, Guresh Kumar, et al.Liver International : Official Journal of the International Association for the Study of the Liver|July 30, 2019
Efficacy and safety of transjugular intrahepatic portosystemic shunt in difficult-to-manage hydrothorax in cirrhosisAnkur Jindal, Amar Mukund, Guresh Kumar, et al.Canadian Journal of Physiology and Pharmacology|October 23, 2013
2-(4-substituted piperazin-1-yl)-1,8-naphthyridine-3-carboxylic acids: novel 5-HT3 receptor antagonists with anxiolytic-like activity in rodent behavioral modelsRadhakrishnan Mahesh, Arghya Kusum Dhar, Ankur Jindal, et al.Pageof 50